Tomas Olsson

Has grant

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Multiple sclerosis; cross-disciplinary studies of causes, pathogenesis and treatment strategies

Open Date: 2014-01-01

Close Date: 2016-12-01

Grant: Close

Multiple sclerosis-A systematic integration of clinical, biomarker, genetic and epidemiological data for the definition of disease pathogenesis and therapeutic targets.

Open Date: 2014-01-01

Close Date: 2018-12-01

Grant: Close

Pathogenesis and Genetics of neuroinflammation with a focus on multiple sclerosis

Open Date: 2013-01-01

Close Date: 2017-12-01

Grant: Close

Autoimmune diseases: new approaches for understanding and to develop prevention and therapy.

Open Date: 2012-01-01

Close Date: 2016-12-01

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Lars Alfredsson

Healthcare Provision, Stockholm County

SWEDEN

View details

Mohsen Khademi

Karolinska Institutet

SWEDEN

View details

Kelsi Smith

Karolinska Institutet

SWEDEN

View details

Daniel Ferreira

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tomas Olsson

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology

Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology

Comorbid disease burden among MS patients 1968-2012: A Swedish register-based cohort study

DRB1-environment interactions in multiple sclerosis etiology: results from two Swedish case-control studies

Epstein-Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis

Higher body mass index at ages 16 to 20 years is associated with increased risk of a multiple sclerosis diagnosis in subsequent adulthood among men

Hospital-diagnosed infections before age 20 and risk of a subsequent multiple sclerosis diagnosis

Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activity

Reduction of the risk of PML in natalizumab treated MS patients in Sweden: An effect of improved PML risk surveillance

Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study

Collaborators (4)

Lars Alfredsson

Mohsen Khademi

Kelsi Smith

Daniel Ferreira

Make your next move.